Research output per year
Research output per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Related documents
Education/Academic qualification
Ph.D., Nagoya City University
External positions
Faculty of Pharmaceutical Sciences, Teikyo University
Apr 2024 → …
National Institute of Health Sciences Tokyo
Apr 2021 → Mar 2024
Japan Agency for Medical Research and Development
Apr 2019 → Mar 2021
National Institute of Health Sciences Tokyo
Oct 2000 → Mar 2019
Keywords
- Drug-induced Liver Injury
- HLA
- Severe Cutaneous Adverse Reactions
- Serious Adverse Drug Reactions
- Genome-wide Association Study
- IgE Crosslinking-induced Luciferase Expression test
- mast cells
- IgE
- EXiLE
- allergy
Research Fields
- Clinical pharmacy
- Gastroenterology
- Dermatology
- Pharmaceutical chemistry and drug development sciences
- Pharmacology
- Pharmaceutical hygiene and biochemistry
Fingerprint
Dive into the research topics where RIYOUSUKE NAKAMURA is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Fenugreek inhibits cathepsin G activity and suppresses the progression of malignant phenotypes in MCF-7 cells
Tanigawa, K., Tanikawa, T., Kitamura, M., Hayashi, Y., Kiriya, M., Nakamura, Y., Kawashima, A., Fujiwara, Y., Morimoto-Kamata, R., Ohkura, N., Yui, S., Karasawa, K., nakamura, R. & Suzuki, K., Jun 2025, In: Biochemistry and Biophysics Reports. 42, 102021.Research output: Contribution to journal › Article › peer-review
Open Access -
Association of HLA-A∗11:01, HLA-B∗39:01, and HLA-B∗56:03 with salazosulfapyridine-induced cutaneous adverse drug reactions
Fukunaga, K., Tsukagoshi, E., Nakamura, R., Matsunaga, K., Ozeki, T., Watanabe, H., Hasegawa, A., Hama, N., Kurata, M., Mizukawa, Y., Watanabe, Y., Yamaguchi, Y., Niihara, H., Morita, E., Asada, H., Abe, R., Saito, Y. & Mushiroda, T., May 2024, In: Journal of Allergy and Clinical Immunology: In Practice. 12, 5, p. 1355-1358.e3Research output: Contribution to journal › Article › peer-review
5 Scopus citations -
Clinical Profiles of Japanese Patients with Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis Collected by a Nationwide System from 2006 to 2023
Tsukagoshi, E., Nakamura, R., Kaniwa, N., Sai, K., Kikura-Hanajiri, R., Matsunaga, K., Abe, R., Asada, H. & Saito, Y., 2024, In: Biological and Pharmaceutical Bulletin. 47, 1, p. 88-97 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Consideration of the EXiLE test for predicting anaphylaxis after diclofenac etalhyaluronate administration
Akiyama, H., Kurisaka, C., Muramatsu, D., Takada, S., Toyama, K., Yoshioka, K. & Nakamura, R., 2024, In: Journal of Immunotoxicology. 21, 1, 2417758.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Differential Effects of HLA-B∗15:11 and HLA-A∗31:01 on Carbamazepine-Induced Cutaneous Adverse Reactions
Fukunaga, K., Tsukagoshi, E., Kurata, M., Mizukawa, Y., Niihara, H., Morita, E., Watanabe, Y., Yamaguchi, Y., Watanabe, H., Nakajima, S., Nomura, T., Kabashima, K., Tohyama, M., Azukizawa, H., Asada, H., Hasegawa, A., Hama, N., Ozeki, T., Mashimo, Y. & Sekine, A. & 6 others, , Apr 2024, In: Journal of Investigative Dermatology. 144, 4, p. 908-911.e7Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations